Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06869057 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Re-Engineered Discharge for Diabetes Care Transitions

Study acronym: REDDCAT2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Study sites: 0 to 1
    • Start date changed from estimate of May 1, 2026 to Jun 8, 2026
    v8
  2. Start date: Feb 1, 2026 to May 1, 2026v7
  3. Start date: Dec 1, 2025 to Feb 1, 2026v6
  4. Start date: Aug 1, 2025 to Dec 1, 2025
    • Secondary endpoints: details revised at 2 of 22 entries
    v5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Dec 2028 to Dec 1, 2028
    • Study completion date: May 2029 to May 30, 2029
    v3
  2. Start date: May 10, 2025 to Aug 1, 2025
    • Primary completion date: Aug 2028 to Dec 2028
    • Study completion date: Oct 2029 to May 2029
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this project is to test a novel bedside SDOH screening intervention coupled with post-discharge navigation for hospitalized patients with a diabetes diagnosis to reduce unmet social needs, compared to usual care.
Trial Details
NCT Number NCT06869057
Lead Sponsor University of Massachusetts, Worcester
Collaborators: National Institute of Nursing Research (NINR), Regents of the University of Michigan
Conditions
(from sponsor)		 Diabetes Mellitus Type 2, Social Determinants of Health (SDOH), Hospital Readmission
Related terms Diabetes Mellitus, Diabetes Mellitus, Type 2
Enrollment 412 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov